Summary: After transfer from the environment, Legionella species may cause pneumonias or influenza‐like respiratory infections. The diagnostic methods currently available, such as culture, serology, direct fluorescent antibody testing, and urinary antigen detection, still constitute the basic diagnostic repertoire. However, none of the diagnostic tests presently available offers the desired quality with respect to sensitivity and specificity. Therefore, the standard performance is to use several diagnostic tests in parallel. Culture should be obligatory especially when hospitalized patients with underlying diseases are investigated. Urinary antigen detection is a valuable tool when L. pneumophila serogroup 1 is the causative agent. This is the case in the majority of community acquired cases. For the surveillance of nosocomial legionellosis, direct fluorescence antigen detection may be of greater value since this test detects all serogroups of L. pneumophila. The detection of antibodies in patient's sera is still a good laboratory test but is of little use in the acute phase of illness. Recently significant advances have been made in the development of diagnostic tests which are based on the detection of nucleic acids, most notably the polymerase chain reaction.